Carles Ràfols

New Oral Anticoagulants vs Vitamin K Antagonists: Benefits for Health-Related Quality of Life in Patients with Atrial Fibrillation

Josep M. Alegret, Xavier Viñolas, Miguel Á. Arias et al. · International Journal of Medical Sciences · 2014 · 29 citations · Full text

Benefits of Emergency Departments’ Contribution to Stroke Prophylaxis in Atrial Fibrillation

Blanca Coll‐Vinent, Alfonso Martı́n, Juan Carlos Martín‐Sánchez et al. · Stroke · 2017 · 24 citations · Full text

Type and doses of oral anticoagulants and adherence to anticoagulant treatment in elderly patients with atrial fibrillation: the ESPARTA study

José María Mostaza, Carmen Suárez Fernández, Luis Castilla Guerra et al. · Journal of Comparative Effectiveness Research · 2018 · 18 citations

Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: impact of inappropriate doses (the EMIR study)

Marcelo Sanmartı́n, Carles Ràfols, Fernando Arribas et al. · Journal of Comparative Effectiveness Research · 2021 · 17 citations

Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry

María Asunción Esteve‐Pastor, José Miguel Rivera‐Caravaca, Vanessa Roldán et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 2022 · 15 citations